● Recruiting

A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

Condition: Rectal Cancer · Sponsor: Osaka University

PhasePhase 2

Planned participants45

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A multicenter single-arm phase 2 study to evaluate safety and efficacy of the total neoadjuvant therapy of short course radiation therapy followed by neoadjuvant oxaliplatin/fluorouracil-based chemotherapy (CAPOX) for cT2 rectal cancer

This description comes directly from the study's public registry record.

Talk to the study team

Mamoru Uemura, MD, PhD · +81-6-6879-3251 · muemura@gesurg.med.osaka-u.ac.jp

Yoshinori Kagawa, MD, PhD · +81-6-6692-1201 · yoshikagawa@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Osaka General Medical Center	Osaka, Japan	Recruiting
Osaka University Hospital	Osaka, Japan	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05939661